Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 2
2010 1
2012 1
2013 4
2014 5
2016 2
2017 3
2018 4
2019 10
2020 7
2021 4
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Endocrinología, Diabetes y Nutrición: Year in Review 2021.
Zafon C, Caixàs A, Ballesteros M, Menéndez E, Gimeno JA, Fajardo C, Wägner AM. Zafon C, et al. Among authors: fajardo c. Endocrinol Diabetes Nutr (Engl Ed). 2021 Dec;68(10):677-679. doi: 10.1016/j.endien.2021.10.010. Epub 2021 Dec 8. Endocrinol Diabetes Nutr (Engl Ed). 2021. PMID: 34924155 No abstract available.
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Lamas C, Cámara R, Fajardo C, Remon-Ruiz P, Biagetti B, Guerrero-Pérez F, Araujo-Castro M, Mora M, Hanzu F, Iglesias P, García-Centeno R, Soto A. Lamas C, et al. Among authors: fajardo c. Front Endocrinol (Lausanne). 2023 Aug 31;14:1204206. doi: 10.3389/fendo.2023.1204206. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720528 Free PMC article.
Preference of acromegaly patients for treatment attributes in Spain.
Fajardo C, Álvarez-Escola C, Biagetti B, Garcia-Centeno R, Ciriza R, Sánchez-Cenizo L, Díaz-Muñoz M. Fajardo C, et al. Endocrine. 2023 Nov;82(2):379-389. doi: 10.1007/s12020-023-03462-z. Epub 2023 Jul 28. Endocrine. 2023. PMID: 37507554 Free PMC article.
[Neuroendocrinology in 2011].
Puig Domingo M, Castaño J, Alvarez-Escolá C, Resmini E, Venegas E, García Arnés J, Torres E, Lecumberri B, Barahona MJ, Lamas C, Fajardo C, Cámara R, Vicente A, Blanco C, Villabona C, Del Pozo C, Halperin I, Salinas I, Sesmilo G, Aller J, Marazuela M, Webb SM, Bernabeu I. Puig Domingo M, et al. Among authors: fajardo c. Endocrinol Nutr. 2012 May;59(5):311-25. doi: 10.1016/j.endonu.2012.01.009. Epub 2012 Mar 16. Endocrinol Nutr. 2012. PMID: 22425316 Spanish. No abstract available.
DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
García-Martínez A, Sottile J, Sánchez-Tejada L, Fajardo C, Cámara R, Lamas C, Barberá VM, Picó A. García-Martínez A, et al. Among authors: fajardo c. J Clin Endocrinol Metab. 2019 Apr 1;104(4):1272-1282. doi: 10.1210/jc.2018-01856. J Clin Endocrinol Metab. 2019. PMID: 30423170
46 results